Literature DB >> 9030686

Phosphorylation of the ASF/SF2 RS domain affects both protein-protein and protein-RNA interactions and is necessary for splicing.

S H Xiao1, J L Manley.   

Abstract

ASF/SF2 is a member of a conserved family of splicing factors known as SR proteins. These proteins, which are necessary for splicing in vitro, contain one or two amino-terminal RNP-type RNA-binding domains and an extensively phosphorylated carboxy-terminal region enriched in repeating Arg-Ser dipeptides (RS domains). Previous studies have suggested that RS domains participate in protein-protein interactions with other RS domain-containing proteins. Here we provide evidence that the RS domain of unphosphorylated recombinant ASF/SF2 is necessary, but not sufficient, for binding to the U1 snRNP-specific 70-kD protein (70K) in vitro. An apparent interaction of the isolated RS domain with 70K was observed if contaminating RNA was not removed, suggesting a nonspecific bridging between the basic RS domain, RNA, and 70K. In vitro phosphorylation of recombinant ASF/SF2 both significantly enhanced binding to 70K and also eliminated the RS domain-RNA interaction. Providing evidence that these interactions are relevant to splicing, ASF/SF2 can bind selectively to U1 snRNP in an RS domain-dependent, phosphorylation-enhanced manner. We also describe conditions that reveal for the first time a phosphorylation requirement for ASF/SF2 splicing activity in vitro.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9030686     DOI: 10.1101/gad.11.3.334

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  171 in total

1.  Identification and characterization of a novel serine-arginine-rich splicing regulatory protein.

Authors:  D C Barnard; J G Patton
Journal:  Mol Cell Biol       Date:  2000-05       Impact factor: 4.272

2.  Identification of two human nuclear proteins that recognise the cytosine-rich strand of human telomeres in vitro.

Authors:  L Lacroix; H Liénard; E Labourier; M Djavaheri-Mergny; J Lacoste; H Leffers; J Tazi; C Hélène; J L Mergny
Journal:  Nucleic Acids Res       Date:  2000-04-01       Impact factor: 16.971

3.  The splicing factors 9G8 and SRp20 transactivate splicing through different and specific enhancers.

Authors:  Y Cavaloc; C F Bourgeois; L Kister; J Stévenin
Journal:  RNA       Date:  1999-03       Impact factor: 4.942

4.  Participation of the C-terminal domain of RNA polymerase II in exon definition during pre-mRNA splicing.

Authors:  C Zeng; S M Berget
Journal:  Mol Cell Biol       Date:  2000-11       Impact factor: 4.272

5.  Regulation of alternative splicing by SRrp86 through coactivation and repression of specific SR proteins.

Authors:  Daron C Barnard; Jun Li; Rui Peng; James G Patton
Journal:  RNA       Date:  2002-04       Impact factor: 4.942

Review 6.  Sorting out the complexity of SR protein functions.

Authors:  B R Graveley
Journal:  RNA       Date:  2000-09       Impact factor: 4.942

7.  Alternative splicing modulation by a LAMMER kinase impinges on developmental and transcriptome expression.

Authors:  Sigal Savaldi-Goldstein; Dvora Aviv; Olga Davydov; Robert Fluhr
Journal:  Plant Cell       Date:  2003-04       Impact factor: 11.277

Review 8.  T' proteins influence JC virus biology.

Authors:  Richard J Frisque; Brigitte Bollag; Shiva K Tyagarajan; Lisa H Kilpatrick
Journal:  J Neurovirol       Date:  2003       Impact factor: 2.643

9.  PSKH1, a novel splice factor compartment-associated serine kinase.

Authors:  Gaute Brede; Jorun Solheim; Hans Prydz
Journal:  Nucleic Acids Res       Date:  2002-12-01       Impact factor: 16.971

10.  Multiple roles for SR proteins in trans splicing.

Authors:  Suzanne Furuyama; James P Bruzik
Journal:  Mol Cell Biol       Date:  2002-08       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.